Overview

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Status:
Completed
Trial end date:
2001-09-30
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of daptomycin in adults who have pneumonia due to Streptococcus pneumoniae.
Phase:
Phase 3
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Ceftriaxone
Daptomycin